US20060112965A1 - Chewing tobacco substitute containing cotinine - Google Patents
Chewing tobacco substitute containing cotinine Download PDFInfo
- Publication number
- US20060112965A1 US20060112965A1 US11/334,235 US33423506A US2006112965A1 US 20060112965 A1 US20060112965 A1 US 20060112965A1 US 33423506 A US33423506 A US 33423506A US 2006112965 A1 US2006112965 A1 US 2006112965A1
- Authority
- US
- United States
- Prior art keywords
- tobacco
- nicotine
- chewing tobacco
- substitute
- chewing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000208125 Nicotiana Species 0.000 title claims abstract description 58
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 58
- 230000001055 chewing effect Effects 0.000 title claims abstract description 30
- UIKROCXWUNQSPJ-VIFPVBQESA-N (-)-cotinine Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN=C1 UIKROCXWUNQSPJ-VIFPVBQESA-N 0.000 title claims description 8
- UIKROCXWUNQSPJ-UHFFFAOYSA-N Cotinine Natural products C1CC(=O)N(C)C1C1=CC=CN=C1 UIKROCXWUNQSPJ-UHFFFAOYSA-N 0.000 title claims description 8
- 229950006073 cotinine Drugs 0.000 title claims description 8
- 239000000126 substance Substances 0.000 claims description 14
- 239000004909 Moisturizer Substances 0.000 claims description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 11
- 230000001333 moisturizer Effects 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 6
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 5
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 5
- 239000001099 ammonium carbonate Substances 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 235000017550 sodium carbonate Nutrition 0.000 claims description 5
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 4
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- 235000010216 calcium carbonate Nutrition 0.000 claims description 4
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 239000001508 potassium citrate Substances 0.000 claims description 2
- 229960002635 potassium citrate Drugs 0.000 claims description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 2
- 235000011082 potassium citrates Nutrition 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 235000011083 sodium citrates Nutrition 0.000 claims description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 46
- 229960002715 nicotine Drugs 0.000 abstract description 40
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 40
- 239000000654 additive Substances 0.000 abstract description 7
- 230000009931 harmful effect Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- -1 nicotine compound Chemical class 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 19
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 229960001698 nicotine polacrilex Drugs 0.000 description 6
- 206010012335 Dependence Diseases 0.000 description 5
- 235000019505 tobacco product Nutrition 0.000 description 5
- 235000019504 cigarettes Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000246386 Mentha pulegium Species 0.000 description 3
- 235000016257 Mentha pulegium Nutrition 0.000 description 3
- 235000004357 Mentha x piperita Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000001050 hortel pimenta Nutrition 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- FLAQQSHRLBFIEZ-UHFFFAOYSA-N N-Methyl-N-nitroso-4-oxo-4-(3-pyridyl)butyl amine Chemical compound O=NN(C)CCCC(=O)C1=CC=CN=C1 FLAQQSHRLBFIEZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 238000001723 curing Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 241000208140 Acer Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000748095 Hymenopappus filifolius Species 0.000 description 1
- 206010062038 Lip neoplasm Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 206010043515 Throat cancer Diseases 0.000 description 1
- 240000001260 Tropaeolum majus Species 0.000 description 1
- 235000004424 Tropaeolum majus Nutrition 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 244000047670 Viola x wittrockiana Species 0.000 description 1
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
Definitions
- Cigarette smoke is known to cause lung and other cancers as well as have other deleterious effects on the body, e.g., skin, teeth, etc.
- chewing tobacco is known to cause lip, mouth, and throat cancers, among others.
- Certain substitute products incorporate some amount of tobacco along with other ingredients, essentially cutting the amount of harmful tobacco in each dose.
- Other chewing tobacco substitutes are in the form of leafy materials that emulate the feel of tobacco; however, these products do not contain nicotine or any similar chemical. As a result, these substitutes do not have any mechanism for breaking the chemical addiction.
- nicotine-containing replacement products are generally aimed at cigarette users. These products are only in gum, lozenge, or tablet form and deliver nicotine through oral ingestion.
- the gum is a mixture of nicotine polacrilex, gum, flavorants, and aspartame.
- the lozenge is configured with similar ingredients to those of the gum, but in lozenge form.
- the tablets are compressed tobacco, with other natural ingredients. The tablets are to be chewed and swallowed, thereby giving the user the desired nicotine.
- the invention is a chewing tobacco substitute made from natural leaves and additives which simulate the taste and consistency of chewing tobacco to which nicotine polacrilex or cotinine is added.
- the invention allows those addicted to chewing tobacco to chew and receive nicotine without incurring the other harmful side effects of tobacco.
- the product is provided with varying levels of nicotine
- the tobacco-free blends of the present invention combine a leaf-like ingredient, such as tea, peppermint, cabbage, and other plant leaves, with a moisturizer, an alkaline chemical to adjust the ph balance of the blend, and a type of nicotine that can be absorbed through the mouth. Additional additives may also be used, such as natural and artificial flavorants to create flavors and smells that emulate moist tobacco products.
- the blend may have the same taste as chewing tobacco, or may have some other pleasing taste such as peppermint or orange.
- the leaf-like material is used to provide a product that has the same look and feel as tobacco.
- addiction to chewing tobacco is both a physiological addiction to nicotine, as well as a psychological addiction to the act of chewing the chewing tobacco.
- the invention satisfies this psychological addiction by providing a product that looks and feels and can be chewed and expectorated in the same way as chewing tobacco.
- the flavor and smell of tobacco are also simulated thereby further meeting the psychological needs of the user.
- mint leaves such as spearmint or peppermint
- all of the following natural materials could potentially be used: bak choy cabbage leave chrysanthemum leaves collard leaves maple leaves mint leaves nasturtium leaves Oriental greens petunia leaves pansy leaves salvia leaves spearmint leaves spinach leaves sugar cane tannecetum leaves viola leaves Any other type of material, whether natural or man-made could be that provides a feel similar to tobacco.
- herbal leaves are readily used with the invention other parts of plants such as roots, stems and cane may also be used, when properly shredded and processed, in place of or in combination with such leaves. These leaf-like materials may be used separately or in combinations.
- alkaline chemical is also added to the mixture so that the mixture has a ph level between 5.0 and 7.0, and preferably between 6.0 and 6.5. Nicotine is best absorbed in the mouth at ph level between 6.0 and 6.5.
- the leaf-like ingredients above typically are acidic and have a ph level below 6.0 and some cases below 5.0. Therefore, the alkaline (i.e. base) chemical is added to enhance the absorption of nicotine through the mouth.
- the alkaline chemical should be non-toxic. Calcium carbonate, sodium bicarbonate, sodium carbonate, ammonium bicarbonate, potassium citrate, sodium citrate and citric acid are satisfactory alkaline chemicals. Other alkaline chemicals that are safe for human ingestion may also be used.
- a nicotine compound capable of being absorbed through the mouth is also added to the mixture.
- Nicotine is best absorbed in the mouth through in the area between the gum and cheek.
- Nicotine polacrilex is used as a nicotine additive in the current invention.
- This blending of nicotine allows users to continue enjoying the gratifying effects of nicotine, while avoiding the dangerous aspects of tobacco-based products, such as the known carcinogens.
- the present invention can incorporate any nicotine derivative, analog, or variant that is safe for oral contact and has a similar mechanism of action to naturally occurring nicotine found in tobacco products.
- the present invention may be distributed as a line of nicotine-reduced products, including, a line of products beginning with levels similar to that of chewing tobacco and stepping the user down through versions with gradually reduced nicotine content.
- the controlled amounts of nicotine also enable tobacco users to wean themselves off of tobacco and nicotine products altogether.
- the blends of the present invention can be used as a tobacco-free alternative to moist tobacco or as a mechanism for gradually ceasing use of tobacco and nicotine products, i.e., stepping down the levels of nicotine.
- a moisturizer is added to the leaf-like ingredient to give it the same degree of moisturizer as chewing tobacco.
- a moisturizer is desirable since some of the leaf-like materials above are not intrinsically as moist as tobacco leaves, and further because the process of curing, drying, cutting and processing the leaves, as with tobacco, removes most of the moisture.
- a moisturizer is added to the processed leave to give the product a moist and pleasing look and feel.
- Glycerin has been found to be useful as a moisturizer, although the invention is not intended to be limited to any particular type of moisturizer. Indeed any non-toxic moisturizer can be used.
- additives may be used in the mixture as well to enhance its flavor or smell or to act as a preservative.
- potassium sorbate is used as a preservative.
- Such additives are well known in the food and drug industry and will not be further described herein but are meant to be within the scope of the invention.
- compositions of the present invention are intended for the snuff and loose leaf tobacco user.
- the compositions are created to look, feel, and taste like tobacco-based products.
- the compositions are designed to be a moist loose leafed or finely cut leaf product that are placed between the gum and cheek allowing nicotine to be absorbed by the gum and cheek membranes.
- the moisture from the moist blend is typically expectorated.
- a small amount of tobacco may be included in order to enhance the tobacco flavor and feel of the product.
- the mixture may be contained in a pores pouch.
- chewing tobacco substitute is also meant to include snuff substitute and such pouches.
- the compositions of the present invention are substantially in the form of the tobacco products that they are replacing, i.e., loose, leafy form. This should ease the transition to these compositions as the activity of the user (i.e., “dipping” and expectorating) is nearly identical.
- nicotine is administered through the cheek and gum and not necessarily from ingestion or inhalation. This allows nicotine uptake without contact with the digestive system; this can prevent irritation or other possible harmful effects to the stomach or other organs.
- the compositions of the present invention can allow those with conditions affecting the digestive system who would not normally be able to ingest nicotine to use a nicotine-containing substitute.
- the herbaceous material first goes through a curing process, in which it is heated and dried. It is then hydrated in an aqueous solution containing water, natural and artificial flavorings, and potassium sorbate. After the hydration process, glycerin, sodium bicarbonate, sodium carbonate and/or ammonium carbonate, and nicotine polacrilex or other forms of ingestible nicotine are mixed with the product. The sodium bicarbonate/carbonate is added to create the proper pH levels for free nicotine release.
- cotinine is used as the nicotine replacement instead of nicotine polacrilex as described above.
- Cotinine is a chemical derivative of nicotine which results after the human body has broken down nicotine. It is also know in the art to produce cotinine in the laboratory. The following amounts of chemicals are added per 34 grams of leaf (or other tobacco substitute) product:
- the present invention is nevertheless not intended to be limited to the details shown. Rather, the present invention is directed to a leafy tobacco substitute containing nicotine, and a method of making the substitute, and various modifications may be made in the details within the scope and range of equivalents of the description and without departing from the spirit of the invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention is a chewing tobacco substitute made from natural leaves and additives which simulate the taste and consistency of chewing tobacco to which a nicotine compound is added. The invention allows those addicted to chewing tobacco to chew and receive nicotine without incurring the other harmful side effects of tobacco. In one embodiment of the invention the product is provided with varying levels of nicotine.
Description
- The application is a continuation-in-part of U.S. application Ser. No. 10/915,129 filed on Aug. 10, 2004, which claims the benefit of U.S. Provisional Application No. 60/494,420 filed on Aug. 11, 2003, which is incorporated herein by reference
- For many years, it has been demonstrated that tobacco use is harmful, whether from cigarette or cigar smoking or tobacco chewing. Cured tobacco is known to contain a number of nitrosamines, including the harmful carcinogens N′-nitrosonomicotine (NNN) and 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK). Cigarette smoke is known to cause lung and other cancers as well as have other deleterious effects on the body, e.g., skin, teeth, etc. In addition, chewing tobacco is known to cause lip, mouth, and throat cancers, among others. Despite this knowledge, individuals continue to use tobacco products and many become addicted to these products. Accordingly, there have been many attempts at products and methods to assist cigarette smokers and other tobacco users to quit tobacco use.
- Certain substitute products incorporate some amount of tobacco along with other ingredients, essentially cutting the amount of harmful tobacco in each dose. Other chewing tobacco substitutes are in the form of leafy materials that emulate the feel of tobacco; however, these products do not contain nicotine or any similar chemical. As a result, these substitutes do not have any mechanism for breaking the chemical addiction.
- In contrast, current nicotine-containing replacement products are generally aimed at cigarette users. These products are only in gum, lozenge, or tablet form and deliver nicotine through oral ingestion. The gum is a mixture of nicotine polacrilex, gum, flavorants, and aspartame. The lozenge is configured with similar ingredients to those of the gum, but in lozenge form. The tablets are compressed tobacco, with other natural ingredients. The tablets are to be chewed and swallowed, thereby giving the user the desired nicotine.
- There is a need for a tobacco-free chewing tobacco substitute that is used and feels like chewing tobacco products and contains some amount of nicotine.
- The invention is a chewing tobacco substitute made from natural leaves and additives which simulate the taste and consistency of chewing tobacco to which nicotine polacrilex or cotinine is added. The invention allows those addicted to chewing tobacco to chew and receive nicotine without incurring the other harmful side effects of tobacco. In one embodiment of the invention the product is provided with varying levels of nicotine
- The tobacco-free blends of the present invention combine a leaf-like ingredient, such as tea, peppermint, cabbage, and other plant leaves, with a moisturizer, an alkaline chemical to adjust the ph balance of the blend, and a type of nicotine that can be absorbed through the mouth. Additional additives may also be used, such as natural and artificial flavorants to create flavors and smells that emulate moist tobacco products. The blend may have the same taste as chewing tobacco, or may have some other pleasing taste such as peppermint or orange.
- The leaf-like material is used to provide a product that has the same look and feel as tobacco. This is an important aspect of the invention since addiction to chewing tobacco is both a physiological addiction to nicotine, as well as a psychological addiction to the act of chewing the chewing tobacco. The invention satisfies this psychological addiction by providing a product that looks and feels and can be chewed and expectorated in the same way as chewing tobacco. In one preferred embodiment, the flavor and smell of tobacco are also simulated thereby further meeting the psychological needs of the user. While the inventor has found one effective leaf (or combination of leaves) to be tea leaves with mint leaves (such as spearmint or peppermint), all of the following natural materials could potentially be used:
bak choy cabbage leave chrysanthemum leaves collard leaves maple leaves mint leaves nasturtium leaves Oriental greens petunia leaves pansy leaves salvia leaves spearmint leaves spinach leaves sugar cane tannecetum leaves viola leaves
Any other type of material, whether natural or man-made could be that provides a feel similar to tobacco. While herbal leaves are readily used with the invention other parts of plants such as roots, stems and cane may also be used, when properly shredded and processed, in place of or in combination with such leaves. These leaf-like materials may be used separately or in combinations. - Some type of alkaline chemical is also added to the mixture so that the mixture has a ph level between 5.0 and 7.0, and preferably between 6.0 and 6.5. Nicotine is best absorbed in the mouth at ph level between 6.0 and 6.5. The leaf-like ingredients above typically are acidic and have a ph level below 6.0 and some cases below 5.0. Therefore, the alkaline (i.e. base) chemical is added to enhance the absorption of nicotine through the mouth. Preferable, the alkaline chemical should be non-toxic. Calcium carbonate, sodium bicarbonate, sodium carbonate, ammonium bicarbonate, potassium citrate, sodium citrate and citric acid are satisfactory alkaline chemicals. Other alkaline chemicals that are safe for human ingestion may also be used.
- Importantly, a nicotine compound capable of being absorbed through the mouth is also added to the mixture. Nicotine is best absorbed in the mouth through in the area between the gum and cheek. Nicotine polacrilex is used as a nicotine additive in the current invention. Any other type of nicotine additive capable of being absorbed through the mouth, whether now known or hereinafter invented, may also be used and is considered to be within the scope of the invention. This blending of nicotine allows users to continue enjoying the gratifying effects of nicotine, while avoiding the dangerous aspects of tobacco-based products, such as the known carcinogens. The present invention can incorporate any nicotine derivative, analog, or variant that is safe for oral contact and has a similar mechanism of action to naturally occurring nicotine found in tobacco products.
- The present invention may be distributed as a line of nicotine-reduced products, including, a line of products beginning with levels similar to that of chewing tobacco and stepping the user down through versions with gradually reduced nicotine content. The controlled amounts of nicotine also enable tobacco users to wean themselves off of tobacco and nicotine products altogether. In other words, the blends of the present invention can be used as a tobacco-free alternative to moist tobacco or as a mechanism for gradually ceasing use of tobacco and nicotine products, i.e., stepping down the levels of nicotine.
- Preferably, a moisturizer is added to the leaf-like ingredient to give it the same degree of moisturizer as chewing tobacco. A moisturizer is desirable since some of the leaf-like materials above are not intrinsically as moist as tobacco leaves, and further because the process of curing, drying, cutting and processing the leaves, as with tobacco, removes most of the moisture. As in the production of regular chewing tobacco, a moisturizer is added to the processed leave to give the product a moist and pleasing look and feel. Glycerin has been found to be useful as a moisturizer, although the invention is not intended to be limited to any particular type of moisturizer. Indeed any non-toxic moisturizer can be used.
- Other common additives may be used in the mixture as well to enhance its flavor or smell or to act as a preservative. In one embodiment potassium sorbate is used as a preservative. Such additives are well known in the food and drug industry and will not be further described herein but are meant to be within the scope of the invention.
- The compositions of the present invention are intended for the snuff and loose leaf tobacco user. The compositions are created to look, feel, and taste like tobacco-based products. The compositions are designed to be a moist loose leafed or finely cut leaf product that are placed between the gum and cheek allowing nicotine to be absorbed by the gum and cheek membranes. The moisture from the moist blend is typically expectorated. Preferably, there is no tobacco whatsoever contained in these compositions. However, in some embodiments, a small amount of tobacco may be included in order to enhance the tobacco flavor and feel of the product. In some embodiments of the invention the mixture may be contained in a pores pouch. As used herein “chewing tobacco substitute” is also meant to include snuff substitute and such pouches.
- Unlike the nicotine replacement products currently available, the compositions of the present invention are substantially in the form of the tobacco products that they are replacing, i.e., loose, leafy form. This should ease the transition to these compositions as the activity of the user (i.e., “dipping” and expectorating) is nearly identical. In addition, nicotine is administered through the cheek and gum and not necessarily from ingestion or inhalation. This allows nicotine uptake without contact with the digestive system; this can prevent irritation or other possible harmful effects to the stomach or other organs. In addition, the compositions of the present invention can allow those with conditions affecting the digestive system who would not normally be able to ingest nicotine to use a nicotine-containing substitute.
- In one embodiment the following amounts of chemicals are added per 34 grams of leaf (or other tobacco substitute) product:
- (1) 0.1 to 1 g of nicotine polacrilex, or other forms of ingestible nicotine;
- (2) 0.1 to 1 g of sodium bicarbonate, sodium carbonate, calcium carbonate or ammonium bicarbonate; and
- (3) 0.5 to 2 grams of glycerin.
- In one example for preparing the compositions, the herbaceous material first goes through a curing process, in which it is heated and dried. It is then hydrated in an aqueous solution containing water, natural and artificial flavorings, and potassium sorbate. After the hydration process, glycerin, sodium bicarbonate, sodium carbonate and/or ammonium carbonate, and nicotine polacrilex or other forms of ingestible nicotine are mixed with the product. The sodium bicarbonate/carbonate is added to create the proper pH levels for free nicotine release.
- In another embodiment cotinine, is used as the nicotine replacement instead of nicotine polacrilex as described above. Cotinine is a chemical derivative of nicotine which results after the human body has broken down nicotine. It is also know in the art to produce cotinine in the laboratory. The following amounts of chemicals are added per 34 grams of leaf (or other tobacco substitute) product:
- (1) 0.01 to 1 g of cotinine, or other forms of ingestible nicotine;
- (2) 0.1 to 1 g of sodium bicarbonate, sodium carbonate, calcium carbonate or ammonium bicarbonate; and
- (3) 0.5 to 2 grams of glycerin.
- While illustrated and described above with reference to certain specific embodiments, the present invention is nevertheless not intended to be limited to the details shown. Rather, the present invention is directed to a leafy tobacco substitute containing nicotine, and a method of making the substitute, and various modifications may be made in the details within the scope and range of equivalents of the description and without departing from the spirit of the invention.
Claims (9)
1. A chewing tobacco substitute comprised of:
a non-tobacco leaf material;
an alkaline chemical; and
cotinine
2. The chewing tobacco substitute of claim 1 wherein the non-tobacco leaf material is an herbal leaf.
3. The chewing tobacco substitute of claim 1 wherein the alkaline chemical is calcium carbonate, sodium bicarbonate, sodium carbonate, ammonium bicarbonate, potassium citrate, sodium citrate or citric acid.
4. The chewing tobacco substitute of claim 1 wherein the ph level of the substitute is approximately between 5.0 and 7.0.
5. The chewing tobacco substitute of claim 1 wherein the substitute is approximately between 0.03% and 3.5% cotinine by weight.
6. The chewing tobacco substitute of claim 1 wherein the substitute is approximately between 0.7% and 3.5% alkaline chemical by weight.
7. The chewing tobacco substitute of claim 1 further comprised of a moisturizer.
8. The chewing tobacco substitute of claim 7 wherein the moisturizer is glycerin.
9. The chewing tobacco substitute of claim 7 wherein the substitute is approximately between 1.4% and 7% moisturizer by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/334,235 US20060112965A1 (en) | 2003-08-11 | 2006-01-18 | Chewing tobacco substitute containing cotinine |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49442003P | 2003-08-11 | 2003-08-11 | |
US10/915,129 US20050034738A1 (en) | 2003-08-11 | 2004-08-10 | Chewing tobacco substitute containing nicotine |
US11/334,235 US20060112965A1 (en) | 2003-08-11 | 2006-01-18 | Chewing tobacco substitute containing cotinine |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/915,129 Continuation-In-Part US20050034738A1 (en) | 2003-08-11 | 2004-08-10 | Chewing tobacco substitute containing nicotine |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060112965A1 true US20060112965A1 (en) | 2006-06-01 |
Family
ID=34138861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/334,235 Abandoned US20060112965A1 (en) | 2003-08-11 | 2006-01-18 | Chewing tobacco substitute containing cotinine |
Country Status (1)
Country | Link |
---|---|
US (1) | US20060112965A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9854830B2 (en) | 2012-01-20 | 2018-01-02 | Altria Client Services Llc | Oral tobacco product |
US9872516B2 (en) | 2012-01-20 | 2018-01-23 | Altria Client Services Llc | Oral product |
US9884015B2 (en) | 2012-01-20 | 2018-02-06 | Altria Client Services Llc | Oral product |
US9930909B2 (en) * | 2012-01-20 | 2018-04-03 | Altria Client Services Llc | Oral product |
US9986756B2 (en) | 2012-01-20 | 2018-06-05 | Altria Client Services Llc | Exhausted-tobacco oral product |
US10952460B2 (en) * | 2018-11-05 | 2021-03-23 | Blesst Boyz LLC | Composition for a tobacco-free chew and method of manufacturing same |
US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
US12342851B2 (en) | 2017-12-08 | 2025-07-01 | Altria Client Services Llc | Smoking article with reduced tobacco |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867951A (en) * | 1971-03-09 | 1975-02-25 | Jamag Basel Ag | Tobacco substitute |
US4694842A (en) * | 1983-09-21 | 1987-09-22 | Kouzou Kobayashi | Tea-containing tobacco |
US4696315A (en) * | 1985-09-19 | 1987-09-29 | Better Life International, Inc. | Herbal snuff composition |
US4811746A (en) * | 1987-05-14 | 1989-03-14 | Davis Lori J | Substitute for oral smokeless tobacco and method of making the same |
US4817640A (en) * | 1985-09-19 | 1989-04-04 | Better Life International Life, Inc. | Herbal chew and snuff compositions |
US4887620A (en) * | 1988-04-26 | 1989-12-19 | Better Life International, Inc. | Composition and method to provide organoleptic bite in a composition for human consumption |
US5417229A (en) * | 1993-07-20 | 1995-05-23 | Summers; John K. | Organoleptic bite composition for human consumption |
US5880164A (en) * | 1995-03-06 | 1999-03-09 | Lectec Corporation | Nicotine-free smoking material |
US6183775B1 (en) * | 1996-05-13 | 2001-02-06 | Novartis Consumer Health S.A. | Buccal delivery system |
US20020117180A1 (en) * | 1997-09-19 | 2002-08-29 | Theodore Hersh | Glutathione, green tea, grape seed extract to neutralize tobacco free radicals |
US20020170567A1 (en) * | 2001-04-06 | 2002-11-21 | John Rizzotto | Chewable flavor delivery system |
US6534527B2 (en) * | 2000-06-02 | 2003-03-18 | Phytos, Inc. | Edible herbal compositions for relieving nicotine craving |
US20030094182A1 (en) * | 2001-09-28 | 2003-05-22 | U.S. Smokeless Tobacco Company | Tobacco mint plant material product |
US20040123873A1 (en) * | 2002-12-31 | 2004-07-01 | Smokey Mountain Chew, Inc. | Nontobacco moist snuff composition |
-
2006
- 2006-01-18 US US11/334,235 patent/US20060112965A1/en not_active Abandoned
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867951A (en) * | 1971-03-09 | 1975-02-25 | Jamag Basel Ag | Tobacco substitute |
US4694842A (en) * | 1983-09-21 | 1987-09-22 | Kouzou Kobayashi | Tea-containing tobacco |
US4696315A (en) * | 1985-09-19 | 1987-09-29 | Better Life International, Inc. | Herbal snuff composition |
US4817640A (en) * | 1985-09-19 | 1989-04-04 | Better Life International Life, Inc. | Herbal chew and snuff compositions |
US4811746A (en) * | 1987-05-14 | 1989-03-14 | Davis Lori J | Substitute for oral smokeless tobacco and method of making the same |
US4887620A (en) * | 1988-04-26 | 1989-12-19 | Better Life International, Inc. | Composition and method to provide organoleptic bite in a composition for human consumption |
US5417229A (en) * | 1993-07-20 | 1995-05-23 | Summers; John K. | Organoleptic bite composition for human consumption |
US5880164A (en) * | 1995-03-06 | 1999-03-09 | Lectec Corporation | Nicotine-free smoking material |
US6183775B1 (en) * | 1996-05-13 | 2001-02-06 | Novartis Consumer Health S.A. | Buccal delivery system |
US20020117180A1 (en) * | 1997-09-19 | 2002-08-29 | Theodore Hersh | Glutathione, green tea, grape seed extract to neutralize tobacco free radicals |
US6534527B2 (en) * | 2000-06-02 | 2003-03-18 | Phytos, Inc. | Edible herbal compositions for relieving nicotine craving |
US20020170567A1 (en) * | 2001-04-06 | 2002-11-21 | John Rizzotto | Chewable flavor delivery system |
US20030094182A1 (en) * | 2001-09-28 | 2003-05-22 | U.S. Smokeless Tobacco Company | Tobacco mint plant material product |
US20040123873A1 (en) * | 2002-12-31 | 2004-07-01 | Smokey Mountain Chew, Inc. | Nontobacco moist snuff composition |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10660359B2 (en) | 2012-01-20 | 2020-05-26 | Altria Client Services Llc | Oral product |
US10959454B2 (en) | 2012-01-20 | 2021-03-30 | Altria Client Services Llc | Oral product |
US9884015B2 (en) | 2012-01-20 | 2018-02-06 | Altria Client Services Llc | Oral product |
US12193470B2 (en) | 2012-01-20 | 2025-01-14 | Altria Client Services Llc | Oral tobacco product |
US9986756B2 (en) | 2012-01-20 | 2018-06-05 | Altria Client Services Llc | Exhausted-tobacco oral product |
US10602768B2 (en) | 2012-01-20 | 2020-03-31 | Altria Client Services Llc | Oral tobacco product |
US10631568B2 (en) | 2012-01-20 | 2020-04-28 | Altria Client Services Llc | Oral product |
US10639275B2 (en) | 2012-01-20 | 2020-05-05 | Altria Client Services Llc | Oral product |
US9872516B2 (en) | 2012-01-20 | 2018-01-23 | Altria Client Services Llc | Oral product |
US9854830B2 (en) | 2012-01-20 | 2018-01-02 | Altria Client Services Llc | Oral tobacco product |
US9930909B2 (en) * | 2012-01-20 | 2018-04-03 | Altria Client Services Llc | Oral product |
US11369129B2 (en) | 2012-01-20 | 2022-06-28 | Altria Client Services Llc | Oral product |
US11541001B2 (en) | 2012-01-20 | 2023-01-03 | Altria Client Services Llc | Oral product |
US11540554B2 (en) | 2012-01-20 | 2023-01-03 | Altria Client Services Llc | Oral tobacco product |
US11864578B2 (en) | 2012-01-20 | 2024-01-09 | Altria Client Services Llc | Oral product |
US12167743B2 (en) | 2012-01-20 | 2024-12-17 | Altria Client Services Llc | Oral product |
US12342851B2 (en) | 2017-12-08 | 2025-07-01 | Altria Client Services Llc | Smoking article with reduced tobacco |
US10952460B2 (en) * | 2018-11-05 | 2021-03-23 | Blesst Boyz LLC | Composition for a tobacco-free chew and method of manufacturing same |
US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050034738A1 (en) | Chewing tobacco substitute containing nicotine | |
US12161145B2 (en) | Inhibition of sensory irritation during consumption of non-smokeable tobacco products | |
KR100370340B1 (en) | Tobacco Substitute Composition | |
US3067068A (en) | Tobacco-like composition | |
US5845647A (en) | Tobacco and related products | |
US7913700B2 (en) | Nontobacco moist snuff composition | |
US20060112965A1 (en) | Chewing tobacco substitute containing cotinine | |
US7578299B2 (en) | Green tea-based substitute for cigarette and method for manufacturing the same | |
US8875716B2 (en) | Oral smokeless tobacco products and oral smokeless non-tobacco snuff products comprising carbamide or carbamide salts | |
EP3868222A1 (en) | Smokeless article | |
JP2023022200A (en) | Pouches containing interconnected active ingredients | |
WO2021053036A1 (en) | A smokeless article | |
KR101257828B1 (en) | Composition of antismoking aid containing damascone | |
CN104026727A (en) | Novel areca-nut type chewing tobacco product | |
EP3868223A1 (en) | Smokeless article | |
EP3868221A1 (en) | Smokeless article | |
US20080017205A1 (en) | Method and Device for Releasing Flavor and Odor Substances | |
KR200412339Y1 (en) | Low nicotine tobacco | |
EP3868224A1 (en) | Smokeless article | |
JP3068084B1 (en) | Tobacco substitute composition | |
EP4467010A1 (en) | Pouched product and method of making | |
RU2832481C1 (en) | Smokeless product containing bamboo fibers with metered amount of nicotine, use of such fibers, method of making said product and kit containing smokeless product | |
WO2025125300A1 (en) | Saliva permeable pouch comprising a moist non-tobacco composition and an active substance | |
EP4505883A1 (en) | Method of manufacturing a smokeless article | |
CA2510059C (en) | Smokeless non-tobacco composition and method for making same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MCMAHON, MR. JOHN, PENNSYLVANIA Free format text: SECURITY AGREEMENT;ASSIGNOR:BLUE WHALE WORLDWIDE;REEL/FRAME:018122/0437 Effective date: 20060709 |
|
AS | Assignment |
Owner name: MCMAHON, JOHN I., PENNSYLVANIA Free format text: SECURITY AGREEMENT;ASSIGNOR:BLUE WHALE WORLDWIDE;REEL/FRAME:018263/0639 Effective date: 20060818 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |